Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease
1 other identifier
observational
48
0 countries
N/A
Brief Summary
Patients with Crohn's disease (CD) could develop complications such as stricture, intestinal fistula and abdominal abscess. Some CD patients had poor response to medical therapy. The efficacy of exclusive enteral nutrition (EEN) to these adult active CD patients is still unclear. The investigators aim to study the efficacy of EEN in induction of remission in adult active CD patients with complications or poor response to drugs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2013
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 25, 2022
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedApril 18, 2023
April 1, 2023
2.2 years
September 25, 2022
April 14, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Clinical remission after 12 weeks EEN
The Crohn's disease activity index (CDAI)\<150 was taken as achieving clinical remission.
July 2013 to October 2015
Mucosal healing after EEN
Mucosal healing was assessed under endoscopy with SES-CD.
July 2013 to October 2015
Secondary Outcomes (4)
The high sensitivity C-reactive protein (mg/L) -Inflammatory parameter assessment
baseline, week 4 and week 12
Inflammatory parameter assessment
baseline, week 4 and week 12
The body mass nutritional parameter assessment
baseline, week 4 and week 12
The albumin (g/L)- nutritional parameter assessment
baseline, week 4 and week 12
Interventions
Eligibility Criteria
All consecutive adult active CD patients followed up in our center and had been diagnosed with disease complications including stricture, intestinal fistula, abdominal abscess or no response to drugs. Patients were recruited from July 2013 to July 2015.
You may qualify if:
- \>18 years old
- Patients with CD was diagnosed clinically according to previously established international criteria \[9\]
- The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation. Intolerance or failure to steroids or IFX was judged by medical history
- The disease was in an active period.
You may not qualify if:
- Intolerant to EEN or need emergency surgery
- The bowel stricture should mainly cause by fibrosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
September 25, 2022
First Posted
April 18, 2023
Study Start
July 1, 2013
Primary Completion
September 1, 2015
Study Completion
September 1, 2015
Last Updated
April 18, 2023
Record last verified: 2023-04